TickerFactsScreenerDevelopers

KalVista Pharmaceuticals, Inc. (KALV) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2012: -$28.29M2013: -$33.71M2014: -$44.18M2015: $49.31M2016: -$37.11M2017: $31.33M2018: $27.25M2019: $96.74M2020: $83.75M2021: $257.19M2022: $185.09M2023: $161.03M2024: $206.58M2025: -$2.71M-$2.71M
2012Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025-$2.71M-101.3%
2024$206.58M+28.3%
2023$161.03M-13.0%
2022$185.09M-28.0%
2021$257.19M+207.1%
2020$83.75M-13.4%
2019$96.74M+255.0%
2018$27.25M-13.0%
2017$31.33M+184.4%
2016-$37.11M-175.3%
2015$49.31M+211.6%
2014-$44.18M-31.1%
2013-$33.71M-19.2%
2012-$28.29M—